DOCSLIB.ORG

Curriculum Vitae Takahiro Shiota, MD, Phd, FACC, FESC, FASE, FAHA

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae Takahiro Shiota, MD, Phd, FACC, FESC, FASE, FAHA 1 Curriculum Vitae Takahiro Shiota, MD, PhD, FACC, FESC, FASE, FAHA Office Address: Cedars-Sinai Medical Center Heart Institute 127 S. San Vicente Blvd., A3411 Los Angeles, CA 90048 (310) 423-6889 Office Email: [email protected] EDUCATION: 1991 Ph.D. in Cardiology. Faculty of Medicine, University of Tokyo, Tokyo, Japan 1977-1983 M.D. Faculty of Medicine, University of Tokyo, Tokyo, Japan 1972-1976 B.S. in Physics. Faculty of Science, University of Tokyo, Tokyo, Japan LICENSURE AND CERTIFICATION National Board of Echocardiography (#2000-252) California Medical License (#000015) Ohio Medical License (#35. 080318) ECFMG (#0-576-045-9) Japanese Medical License (#274951) PROFESSIONAL EXPERIENCE 1/2009-present Associate Director Division of Noninvasive Cardiology Cedars-Sinai Heart Institute Los Angeles, CA 12/2001-12/2008 Clinical Staff Department of Cardiovascular Medicine Cleveland Clinic, Cleveland, OH 7/1999-11/2001 Advanced Cardiac Department of Cardiovascular Medicine Imaging Fellow Cleveland Clinic, Cleveland, OH 9/1997- 6/1999 Project Staff Department of Cardiovascular Medicine 2 Cleveland Clinic, Cleveland, OH 8/1992- 8/1997 Research Director Cardiac Imaging Laboratory, Clinical Care Center for Congenital Heart Disease, Oregon Health Sciences University, Portland, OR PROFESSIONAL ACTIVITIES: Academic Appointment 7/2009-present Professor of Medicine, Department of Medicine, Cedars-Sinai, Los Angeles, CA 8/2008-present Clinical Professor of Medicine, David Geffen School of Medicine at UCLA 7/2007-12/2008 Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 7/2004-6/2007 Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 6/2000-6/2004 Associate Professor of Medicine, Cleveland Clinic Health Sciences Center, Ohio State University School of Medicine, Columbus, OH 7/1997-8/1997 Associate Professor of Medicine, Clinical Care Center for Congenital Heart Disease, Department of Pediatric Cardiology, Oregon Health Sciences University, Portland, OR 7/1993-6/1997 Assistant Professor of Medicine, Clinical Care Center for Congenital Heart Disease, Department of Pediatric Cardiology, Oregon Health Sciences University, Portland, OR 8/1992-6/1993 Instructor, Clinical Care Center for Congenital Heart Disease, Department of Pediatric Cardiology, Oregon Health Sciences University, Portland, OR Society Memberships 1996-Present Fellow of the American College of Cardiology (F.A.C.C.) 2007-Present Fellow of the American Heart Association (F.A.H.A.) 2008-Present Fellow of the European Society of Cardiology (F.E.S.C.) 1996-Present Fellow of the American Society of Echocardiology (F.A.S.E.) 3 Other Professional Activities 1/1/14-Present Board Member of IRB at Cedars Sinai Medical Center 2013-Present Vice President, Asian-Pacific Association of Echocardiography 1/1/13-Present Vice President, Asian-Pacific Association of Echocardiography 1/1/12-12/31/13 President, Los Angeles Society of Echocardiogrphy 1/1/11-Present International Advisory Board Member, Journal of Japanese College of Cardiology 1/1/10-Present International Task Force Representative to Japan, American Society of Echocardiography 1/1/09-12/31/10 Scientific Advisory Board Member, International Academy of Cardiology 1/1/08-12/31/2013 Editor-in-Chief, “Cardiac Ultrasound Today” 9/1/05-8/31/09 Quality Assurance Officer in Cardiology at Cleveland Clinic 1993-Present Abstract grader and peer reviewer for Circulation, Journal of the American College of Cardiology, American Heart Journal, American Journal of Cardiology and Journal of the American Society of Echocardiography. HONORS 2007 “America’s Top Cardiologists” 2014 Highly Commended for 3D Echocardiography 2nd edition at the British Medical Association Medical Book Awards GRANT SUPPORT: 1. R01HL122492 (PI – Chugh, Co-Investigator-Takahiro Shiota) NIH NHLBI Total Costs: $ 2,357,464 Sudden Cardiac Death in Middle Age This study is a population-based translational approach to identify novel mechanisms of ventricular arrhythmogenesis in middle-aged residents of a large community. 11/14/14 – 11/13/18 2. Grant-in-Aid, American Heart Association, Ohio Valley Affiliate. 3-Dimensional echocardiographic evaluation of the heart: Quantitative application for valvular heart disease. Role on Project: Principal Investigator 7/1/99-6/30/01 4 3. National Aeronautics and Space administration. Digital echocardiography in manned space flight: remote diagnosis and quantitative analysis. Role on Project: Co- Investigator. P.I. James D. Thomas, MD. 7/1/97-6/30/99 4. Grant-in-Aid, American Heart Association, Oregon Affiliate. 3-Dimensional modeling of cardiac flow events as imaged by color Doppler echocardiography. Role on Project: Principal Investigator 7/1/97-6/30/99 5. PHS NIH NHLBI (R01 HL43287). Multicenter study of miniaturized multiplane TEE probes. Role on Project: Co-Investigator. P.I. David J. Sahn, MD. 2/1/95- 1/31/98 6. PHS NIH NHLBI (R01 HL36472). Phase array for multiplane esophageal echos in infants. Role on Project: Co-Investigator. P.I. David J. Sahn, MD. 8/1/87-1/31/96 7. PHS NIH NHLBI (R01 HL43287). Improved understanding of cardiac flows. Role on Project: Co-Investigator. P.I. David J. Sahn, MD. 9/1/90-8/31/95 CURRENT RESEARCH PROJECTS 4/1/14-Present Geometry of Postinfarction Ventricular Septal Defect in Comparison with Congenital Ventricular Septal Defect: A Real-Time Three- Dimensional Transesophageal Echocardiography Study. 6/1/14-Present Volume Reduction of Mitral Regurgitation is Main Contributor to Increase of Cardiac Forward Flow in Patients with Preprocedural Mitral Regurgitation after Transcatheter Aortic Valve Replacement: Hemodynamic analysis using echocardiography. 8/1/14-Present Absence of Chordae Tendineae near Valve Coaptation Leads to Mitral Regurgitation in Lone Atrial Fibrillation. INVITED SPEAKER, MODERATOR AND CHAIRPERSON 1. Cardiology Grand Rounds: University of Illinois, Chicago, April 1993. "Quantitation of Mitral Regurgitation Using Doppler Echocardiography" 2. 8th Annual Advances in Echocardiography, Chicago, September 1993. 3. Topics of Faculty Science: Oregon Health Sciences University, Congenital Heart Research Center, February 1994 “Contrast Echocardiography” 5 4. Topics of Faculty Science: Oregon Health Sciences University, March 1994. "Color Doppler flow convergence region of mitral regurgitation" 5. 9th Annual Advances in Echocardiography, Chicago, September 1994. 6. Topics of Faculty Science: Oregon Health Sciences Universitiy, March 1995. “Three-Dimensional Color Doppler Echocardiography” 7. 43rd Annual Scientific Meeting of Japanese College of Cardiology; Yokohama, Japan, September 1995. "Doppler Flow Convergence Quantitation in Aortic and Mitral Regurgitation" 8. 10th Annual Advances in Echocardiography, Chicago, September 1995. 9. Topics of Faculty Science: Oregon Health Sciences University, November 1995. "Digital Phonocardiography of Mitral Regurgitation" 10. Anesthesiology Conference: Oregon Health Sciences University, December 1995. "Three-Dimensional Echocardiography Using Multi-plane Transesophageal Echocardiography" 11. 11th Annual Advances in Echocardiography, Chicago, September 1996. 12. 8th Annual Scientific Sessions of American Society of Echocardiography: Florida, June 1997. Meet the Expert “Automated Cardiac Flow Measurement” 13. Contrast Echocardiography Conference of Japanese Society of Echocardiography: Osaka, Japan, August 1997. “New Development of Contrast Echocardiography” 14. 14th Annual Advances in Echocardiography, Chicago, September 1997. 15. 9th Annual Scientific Sessions of American Society of Echocardiography: San Francisco, June 1998. Meet the Expert “Model Study” 16. 70th Scientific Sessions of American Heart Association, Moderator, How to Session :Dallas, Novemver 1998. “3D Echocardiography, the Past, the Present and the Future” 17. 10th Annual Scientific Sessions of American Society of Echocardiography: Washington DC, June 1999. Symposium “3D Echocardiography” 18. Echo Kobe 2000 Conference of Japanese Society of Echocardiography: Kobe, Japan, July 2000. “Case Studies with Experts” “Echocardiographic Qunatification of Cardiac Function in the Year of 2000” 6 19. Contrast Echocardiography Conference of Japanese Society of Echocardiography: Osaka, Japan, August 2000. “Clinical Applications of Contrast Echocardiography” 20. Cardiothoracic Surgical Grand Rounds, Saitama College of Medicine, Japan, August 2000. “Cardiac Surgery with Echocardiography” 21. Cardiology Grand Rounds: Kawasaki College of Medicine, Kurashiki, Japan, August 2000. “Three Dimensional Echocardiography” 22. 15th Annual Advances in Echocardiography, Chicago, September 2000. “3D Stress Contrast Echocardiography” 23. Cardiology Grand Rounds: Faculty of Medicine, University of Kagoshima, Kagoshima, Japan, August 2001. “3D Echocardiography”, “Medical Education in the United States” 24. American Society of Echocardiography, Faculty and Moderator, Seattle, June 2001. “New Technology” 25. Echo Kobe 2001, Conference of Japanese Society of Echocardiography, Kobe, Japan. July 2001. “3D Echocardiography”, “Case Studies at Cleveland Clinic” 26. Cardiology Grand Rounds: Kawasaki College of Medicine, Kawasaki, Japan, August 2001. “Case studies at Cleveland Clinic” 27. Cardiology Grand Rounds, Faculty of Medicine, University of Kagoshima, Kagoshima, Japan, August 2001 “3D Echocardiography”, “Medical Education in the United States” 28. The Mitral Valve Meeting, Cleveland Clinic, Cleveland,
Load more

Recommended publications
  • A Single Center's Experience with Total Arterial Revascularization and Spiral
    Heart and Vessels (2019) 34:906–915 https://doi.org/10.1007/s00380-018-1317-z ORIGINAL ARTICLE A single center’s experience with total arterial revascularization and spiral aneurysmorrhaphy for ischemic cardiac disease Ilias P. Doulamis1 · Despina N. Perrea1 · George Mastrokostopoulos2 · Konstantina Drakopoulou2 · Konstantinos Voutetakis3 · Aspasia Tzani1 · Ioannis A. Chloroyiannis3 Received: 5 September 2018 / Accepted: 30 November 2018 / Published online: 6 December 2018 © Springer Japan KK, part of Springer Nature 2018 Abstract The restoration of left ventricular (LV) geometry in combination with coronary artery bypass grafting for the treatment of ischemic cardiac disease remains controversial. We hereby present the experience of our center with total arterial myocar- dial revascularization (TAMR) and spiral aneurysmorrhaphy for ischemic heart disease. A retrospective analysis of 101 patients with advanced cardiovascular disease who underwent TAMR and spiral aneurysmorrhaphy was performed. Spiral aneurysmorrhaphy is a modifcation of the linear aneurysmorrhaphy and was applied to patients who had a LV aneurysm with a diameter of less than 5 cm. Peri-operative and in-hospital data were retrieved. The majority of the patients were male (87.13%) with a mean age of 63.1 years. Mean pre-operative ejection fraction (EF) was 35.7% ranging between 20 and 65%. An average of 3.23 grafts was required per patient. Early mortality was 6.93% (one intra-operative and six in-hospital deaths). Addition of concomitant valve surgery was associated with prolonged total operative, cardiopulmonary bypass and cross-clamp time (p < 0.001), increased need for blood (p = 0.012) and plasma (p = 0.038), longer intensive care unit (ICU) stay (p = 0.045) and higher rate of post-operative cerebrovascular accident (p = 0.011).
    [Show full text]
  • Surgery for Acquired Heart Disease
    View metadata, citation and similar papers at core.ac.uk brought to you byCORE provided by Elsevier - Publisher Connector SURGERY FOR ACQUIRED HEART DISEASE EARLY RESULTS WITH PARTIAL LEFT VENTRICULECTOMY Patrick M. McCarthy, MD a Objective: We sought to determine the role of partial left ventriculectomy in Randall C. Starling, MD b patients with dilated cardiomyopathy. Methods: Since May 1996 we have James Wong, MBBS, PhD b performed partial left ventriculectomy in 53 patients, primarily (94%) in Gregory M. Scalia, MBBS b heart transplant candidates. The mean age of the patients was 53 years Tiffany Buda, RN a Rita L. Vargo, MSN, RN a (range 17 to 72 years); 60% were in class IV and 40% in class III. Marlene Goormastic, MPH c Preoperatively, 51 patients were thought to have idiopathic dilated cardio- James D. Thomas, MD b myopathy, one familial cardiomyopathy, and one valvular cardiomyopathy. Nicholas G. Smedira, MD a As our experience accrued we increased the extent of left ventriculectomy James B. Young, MD b and more complex mitral valve repairs. For two patients mitral valve replacement was performed. For 51 patients the anterior and posterior mitral valve leaflets were approximated (Alfieri repair); 47 patients also had ring posterior annuloplasty. In 27 patients (5!%) one or both papillary muscles were divided, additional left ventricular wall was resected, and the papillary muscle heads were reimplanted. Results: Echocardiography showed a significant decrease in left ventricular dimensions after resection (8.3 cm to 5.8 cm), reduction in mitral regurgitation (2.8+ to 0), and increase in forward ejection fraction (15.7% to 32.7%).
    [Show full text]
  • Reduction Ventriculoplasty for Dilated Cardiomyopathy : the Batista Procedure Shahram Salemy Yale University
    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1999 Reduction ventriculoplasty for dilated cardiomyopathy : the Batista procedure Shahram Salemy Yale University Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Recommended Citation Salemy, Shahram, "Reduction ventriculoplasty for dilated cardiomyopathy : the Batista procedure" (1999). Yale Medicine Thesis Digital Library. 3123. http://elischolar.library.yale.edu/ymtdl/3123 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. SlDDCITOM VENTRICULOPIASTy FOR DILATED CARDIOMYOPATHY THE BATISTA PROCEDURE W«M * (e,yx»> ShaLramSalemy YALE DNIVERSriY YALE UNIVERSITY CUSHING/WHITNEY MEDICAL LIBRARY Permission to photocopy or microfilm processing of this thesis for the purpose of individual scholarly consultation or reference is hereby granted by the author. This permission is not to be interpreted as affecting publication of this work or otherwise placing it in the public domain, and the author reserves all rights of ownership guaranteed under common law protection of unpublished manuscripts. Signature of Author Date REDUCTION VENTRICULOPLASTY FOR DILATED CARDIOMYOPATHY: THE BATISTA PROCEDURE Shahram Salemy B.S., George Tellides M.D., Ph.D., and John A. Elefteriades M.D. February 5, 1999 r 113 f'Uh (e(e.cl 0 REDUCTION VENTRICULOPLASTY FOR DILATED CARDIOMYOPATHY: THE BATISTA PROCEDURE.
    [Show full text]
  • Long-Term Outcomes of the Neoaorta After Arterial Switch Operation for Transposition of the Great Arteries Jennifer G
    ORIGINAL ARTICLES: CONGENITAL HEART SURGERY CONGENITAL HEART SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal. CONGENITAL HEART Long-Term Outcomes of the Neoaorta After Arterial Switch Operation for Transposition of the Great Arteries Jennifer G. Co-Vu, MD,* Salil Ginde, MD,* Peter J. Bartz, MD, Peter C. Frommelt, MD, James S. Tweddell, MD, and Michael G. Earing, MD Department of Pediatrics, Division of Pediatric Cardiology, and Department of Internal Medicine, Division of Cardiovascular Medicine, and Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin Background. After the arterial switch operation (ASO) score increased at an average rate of 0.08 per year over for transposition of the great arteries (TGA), the native time after ASO. Freedom from neoaortic root dilation at pulmonary root and valve function in the systemic posi- 1, 5, 10, and 15 years after ASO was 84%, 67%, 47%, and tion, and the long-term risk for neoaortic root dilation 32%, respectively. Risk factors for root dilation include -pre ,(0.003 ؍ and valve regurgitation is currently undefined. The aim history of double-outlet right ventricle (p and length of ,(0.01 ؍ of this study was to determine the prevalence and pro- vious pulmonary artery banding (p Neoaortic valve regurgitation of at .(0.04 ؍ gression of neoaortic root dilation and neoaortic valve follow-up (p regurgitation in patients with TGA repaired with the least moderate degree was present in 14%.
    [Show full text]
  • A Focus on Valve-Sparing Ascending Aortic Aneurysm Repair Newyork
    ADVANCES IN CARDIOLOGY, INTERVENTIONAL CARDIOLOGY, AND CARDIOVASCULAR SURGERY Affiliated with Columbia University College of Physicians and Surgeons and Weill Cornell Medical College A Focus on Valve-Sparing NOVEMBER/DECEMBER 2014 Ascending Aortic Aneurysm Repair Emile A. Bacha, MD The most frequent location for aneurysms in the Chief, Division of Cardiac, chest occurs in the ascending aorta – and these Thoracic and Vascular Surgery aneurysms are often associated with either aortic NewYork-Presbyterian/Columbia stenosis or aortic insufficiency, especially when the University Medical Center aneurysm involves a bicuspid aortic valve. Director, Congenital and Pediatric Cardiac Surgery “We know that patients who have enlarged NewYork-Presbyterian Hospital aortas or aneurysms of the ascending aorta are at [email protected] great risk for one of two major life-threatening events: an aortic rupture or an aortic dissection,” Allan Schwartz, MD says Leonard N. Girardi, MD, Director of Chief, Division of Cardiology Thoracic Aortic Surgery in the Department of NewYork-Presbyterian/Columbia Cardiothoracic Surgery, NewYork-Presbyterian/ University Medical Center Weill Cornell Medical Center. “Dissection of the Valve-sparing ascending aortic aneurysm repair [email protected] inner lining of the wall of the blood vessel can also lead to rupture or other complications down last 15 years, the Aortic Surgery Program at Weill O. Wayne Isom, MD the line. For example, as the tear extends it may Cornell has been aggressively pursuing the devel- Cardiothoracic Surgeon-in-Chief NewYork-Presbyterian/ affect the vessels that supply the brain or the opment of a procedure that would enable surgeons Weill Cornell Medical Center coronary arteries or cause tremendous damage to to spare the patient’s native valve.
    [Show full text]
  • Surgical Ventricular Restoration for Post Infarction Left Ventricular Aneurysm
    Medical Group International Journal of Vascular Surgery and Medicine ISSN: 2455-5452 DOI CC By JR Vijay Kumar, HS Natraj Setty*, Case Report Rajiv Ananthakrishna, Rahul Patil, Seetharama PS Bhat and CN Surgical Ventricular Restoration Manjunath Sri Jayadeva Institute of Cardiovascular Sciences for Post infarction Left Ventricular and Research, Bengaluru, Karnataka, India Dates: Received: 01 January, 2017; Accepted: 21 Aneurysm February, 2017; Published: 24 February, 2017 *Corresponding author: Natraj Setty HS, Doctor, Sri Jayadeva Institute of Cardiovascular Sciences and Abstract Research Bangalore, #493, 4th Cross, 7th Main, JP. Nagar, 3rd Phase, Bangalore – 69, Karnataka, India, Tel: Surgical ventricular restoration is a procedure designed to restore or remodel the left ventricle. Surgical + 9845612322;+ 080-26580051; Fax: + 080-22977261; ventricular restoration by means of the Dor procedure is a surgical option in patients with coronary artery E-Mail: disease, postinfarction left ventricular aneurysm (LV aneurysm) or ischemic dilated cardiomyopathy Keywords: Left ventricular aneurys; Dor procedure; with or without ventricular tachycardia. Postinfarction left ventricular remodeling is characterized by 2D Echo LV dilatation and abnormal geometry leading to systolic and diastolic dysfunction. Development of a left ventricular aneurysm is a serious long-term complication of Acute Myocardial Infarction. We report https://www.peertechz.com a 69 year old male presented with haemodynamically signifi cant ventricular tachycardia, successfully underwent DOR Procedure with complete recovery. Case Profi le by Dor and colleagues [3]. Was introduced to improve geometric reconstruction with respect to standard linear repair in Left A 69 year- old- male, presented with hemodynamically ventricle aneurysm. Subsequently, Dor and colleagues [4]. signifi cant ventricular tachycardia.
    [Show full text]
  • An Extensive Calcified Left Ventricular Aneurysm: Case Report
    OLGU SUNUMU An Extensive Calcified Left Ventricular Aneurysm: Case Report İhsan ALUR, a ABSTRACT A calcified left ventricular aneurysm (CLVA) is a rare, serious complication of acute Tevfik GÜNEŞ, a myocardial infarction. It can lead to angina pectoris, thromboembolism of ventricular origin, ven - a tricular arrhythmia, ventricular pseudoaneurysm or rupture, progressively enlarging aneurysms, Gökhan Yiğit TANRISEVER, congestive heart failure, and death. Treatment is surgical for symptomatic or asymptomatic LVAs a Bilgin EMRECAN larger than 5 cm, particularly when there is comorbid coronay artery disease. Its standard treatment is a ventriculoplasty and aneurysmectomy using the Dor technique. The aim of surgical treatment aDepartment of Cardiovascular Surgery, of an LVA is to reduce oxygen consumption in the LV by reducing end-diastolic volume (EDV), cre - Pamukkale University ating the ideal ventricle geometry, and preventing thrombus formation. The surgical results are Faculty of Medicine, Denizli often good. This article presents a patient with CLVA in whom we performed surgery. Ge liş Ta ri hi/ Re ce i ved: 12.02.2016 Key Words: Heart ventricles; heart aneurysm; thoracic surgery Ka bul Ta ri hi/ Ac cep ted: 04.04.2016 ÖZET Kalsifik sol ventrikül anevrizması (KSVA) akut miyokard infarktüsünün nadir ve ciddi bir Ya zış ma Ad re si/ Cor res pon den ce: komplikasyonudur. Bu komplikasyon anjina pektoris, ventriküler kaynaklı tromboemboli, ventri - İhsan ALUR küler aritmi, ventriküler psödoanevrizma veya rüptür, progresif genişleyen anevrizma ve konjestif Pamukkale University kalp yetersizliği gibi fatal kardiyak olaylara yol açabilir. Semptomatik veya asemptomatik, 5 cm’den Faculty of Medicine, büyük SVA’ların, özellikle eşlik eden koroner arter hastalığı da varsa tedavisi cerrahidir.
    [Show full text]
  • The Memory of the Heart
    Journal of Cardiovascular Development and Disease Review The Memory of the Heart Marco Cirillo Heart Failure Surgery Unit, Cardiac Surgery Unit, Cardiovascular Department, Poliambulanza Foundation Hospital, Via Leonida Bissolati 57, 25125 Brescia, Italy; [email protected]; Tel.: +39-030-351-8088 Received: 2 October 2018; Accepted: 8 November 2018; Published: 11 November 2018 Abstract: The embryological development of the heart is one of the most fascinating phenomena in nature and so is its final structure and function. The various ontogenetic passages form the evolutive basis of the final configuration of the heart. Each key step can be recognized in the final features, as the heart maintains a kind of “memory” of these passages. We can identify the major lines of development of the heart and trace these lines up to the mature organ. The aim of this review is to identify these key parameters of cardiac structure and function as essential elements of the heart’s proper functioning and bases for its treatment. We aim to track key steps of heart development to identify what it “remembers” and maintains in its final form as positively selected. A new vision based on the whole acquired knowledge must guide an in-depth scientific approach in future papers and guidelines on the topic and a complete, farsighted therapeutic conduct able to ensure the physiological correction of cardiac pathologies. The application of this modern, functional vision of the heart could improve the clinical treatment of heart disease, filling the gaps still present. Keywords: heart embryology; myocardial structure; interlaced myocardial fibers; cardiomyopathy; left ventricular reconstruction; heart failure; valve disease; mitral regurgitation; guidelines; cardiac resynchronization 1.
    [Show full text]
  • Heart Valve Disease
    Treatment Guide Heart Valve Disease Heart valve disease refers to any of several condi- TABLE OF CONTENTS tions that prevent one or more of the valves in the What causes valve disease? .................................. 2 heart from functioning adequately to assure prop- er circulation. Left untreated, heart valve disease What are the symptoms of heart valve disease? ....... 5 can reduce quality of life and become life-threat- How is valve disease diagnosed? ............................ 6 ening. In many cases, heart valves can be surgi- What treatments are available? .............................. 8 cally repaired or replaced, restoring normal func- What are the types of valve surgery? ...................... 9 tion and allowing a return to normal activities. What can I expect before and after surgery? .......... 13 Cleveland Clinic’s Sydell and Arnold Miller How can I protect my heart valves? ...................... 17 Family Heart & Vascular Institute is one of the largest centers in the country for the diagnosis and treatment of heart valve disease. The decision to prescribe medical treatment or proceed with USING THIS GUIDE surgical repair or replacement is based on the Please use this guide as a resource as you examine your type of heart valve disease you have, the severity treatment options. Remember, it is every patient’s right of damage, your age and your medical history. to ask questions, and to seek a second opinion. To make an appointment with a heart valve specialist at Cleveland Clinic, call 216.444.6697. CLEVELAND CLINIC | HEART VALVE DISEASE TREATMENT GUIDE About Valve Disease The heart valves How the Valves Work Heart valve disease means one of the heart valves isn’t working properly because The heart has four valves — one for of valvular stenosis (narrowing of the valves) or valvular insufficiency (“leaky” valve).
    [Show full text]
  • Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures Lars G
    Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures Lars G. Svensson, David H. Adams, Robert O. Bonow, Nicholas T. Kouchoukos, D. Craig Miller, Patrick T. O'Gara, David M. Shahian, Hartzell V. Schaff, Cary W. Akins, Joseph E. Bavaria, Eugene H. Blackstone, Tirone E. David, Nimesh D. Desai, Todd M. Dewey, Richard S. D'Agostino, Thomas G. Gleason, Katherine B. Harrington, Susheel Kodali, Samir Kapadia, Martin B. Leon, Brian Lima, Bruce W. Lytle, Michael J. Mack, Michael Reardon, T. Brett Reece, G. Russell Reiss, Eric E. Roselli, Craig R. Smith, Vinod H. Thourani, E. Murat Tuzcu, John Webb and Mathew R. Williams Ann Thorac Surg 2013;95:1-66 DOI: 10.1016/j.athoracsur.2013.01.083 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://ats.ctsnetjournals.org/cgi/content/full/95/6_Supplement/S1 The Annals of Thoracic Surgery is the official journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association. Copyright © 2013 by The Society of Thoracic Surgeons. Print ISSN: 0003-4975; eISSN: 1552-6259. Downloaded from ats.ctsnetjournals.org by on May 28, 2013 SPECIAL REPORT Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures Writing Committee Members: Lars G. Svensson, MD, PhD (Chair), David H. Adams, MD (Vice-Chair), Robert O. Bonow, MD (Vice-Chair), Nicholas T. Kouchoukos, MD (Vice-Chair), D. Craig Miller, MD (Vice-Chair), Patrick T. O’Gara, MD (Vice-Chair), David M. Shahian, MD (Vice-Chair), Hartzell V. Schaff, MD (Vice-Chair), Cary W.
    [Show full text]
  • Surgical Ventricular Restoration
    Surgical Ventricular Restoration Policy # 00184 Original Effective Date: 01/26/2006 Current Effective Date: 06/14/2021 Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the “Company”), unless otherwise provided in the applicable contract. Medical technology is constantly evolving, and we reserve the right to review and update Medical Policy periodically. Services Are Considered Investigational Coverage is not available for investigational medical treatments or procedures, drugs, devices or biological products. Based on review of available data the Company considers surgical ventricular restoration (SVR) for the treatment of ischemic dilated cardiomyopathy to be investigational.* Policy Guidelines Surgical ventricular restoration involves increased physician work compared with standard ventriculectomy. For example, the procedure includes evaluation of the ventricular septum and reshaping of the geometry of the heart. Surgical ventricular restoration is described as a global treatment of left ventricular failure, while conventional left ventricular aneurysmectomy represents a local treatment of a transmural infarct. Background/Overview Surgical ventricular restoration is also known as surgical anterior ventricular endocardial restoration, left ventricular reconstructive surgery, endoventricular circular plasty, or the Dor procedure. Named after the surgeon who pioneered the expansion of techniques for ventricular reconstruction and is credited with treating heart failure patients with SVR and coronary artery bypass grafting. SVR is usually performed after coronary artery bypass grafting and may precede or be followed by mitral valve repair or replacement and other procedures such as endocardectomy and cryoablation for treatment of ventricular tachycardia. A key difference between SVR and ventriculectomy (ie, for aneurysm removal) is that, in SVR, circular “purse string” suturing is used around the border of the aneurysmal scar tissue.
    [Show full text]
  • Medical Policy Surgical Ventricular Restoration
    Medical Policy Surgical Ventricular Restoration Table of Contents Policy: Commercial Coding Information Information Pertaining to All Policies Policy: Medicare Description References Authorization Information Policy History Policy Number: 544 BCBSA Reference Number: 7.01.103 Related Policies None Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Medicare HMO BlueSM and Medicare PPO BlueSM Members Surgical ventricular restoration is INVESTIGATIONAL for the treatment of ischemic dilated cardiomyopathy or post-infarction left ventricular aneurysm. Prior Authorization Information Commercial Members: Managed Care (HMO and POS) This is NOT a covered service. Commercial Members: PPO, and Indemnity This is NOT a covered service. Medicare Members: HMO BlueSM This is NOT a covered service. Medicare Members: PPO BlueSM This is NOT a covered service. CPT Codes / HCPCS Codes / ICD-9 Codes The following codes are included below for informational purposes. Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. Please refer to the member’s contract benefits in effect at the time of service to determine coverage or non-coverage as it applies to an individual member. A draft of future ICD-10 Coding related to this document, as it might look today, is included below for your reference. 1 Providers should report all services using the most up-to-date industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable. CPT Codes CPT codes: Code Description
    [Show full text]